Charlie Bark is an infectious-disease specialist at University Hospitals, Cleveland, USA and assistant professor at Case Western Reserve University School of Medicine, with research interests in the development and research of new anti-Tuberculosis drugs and the understanding of the transmission dynamics of Tuberculosis in high burden settings in low and middle income countries. His current projects include development of new blood-based marker of recent Mycobacterium tuberculosis infection and TB trials. He is an active researcher and investigator with the Uganda-CWRU Research Collaboration with a CDC funded Tuberculosis Trials Consortium (TBTC) and the NIH funded CAPTURE study in Kampala, Uganda.